Olbrich L, Kay A, Bjerrum S, Yang B, Ahsberg J, Nathavitharana R
Cochrane Database Syst Rev. 2025; 5:CD016071.
PMID: 39908066
PMC: 11089514.
DOI: 10.1002/14651858.CD016071.
Ochola E, Mweu M
PLoS One. 2025; 19(12):e0307727.
PMID: 39775245
PMC: 11684650.
DOI: 10.1371/journal.pone.0307727.
Sossen B, Szekely R, Mukoka M, Muyoyeta M, Nakabugo E, Hella J
Lancet Glob Health. 2024; 12(12):e2024-2034.
PMID: 39577975
PMC: 11584317.
DOI: 10.1016/S2214-109X(24)00357-7.
Szekely R, Sossen B, Mukoka M, Muyoyeta M, Nakabugo E, Hella J
PLoS One. 2024; 19(5):e0303846.
PMID: 38820372
PMC: 11142480.
DOI: 10.1371/journal.pone.0303846.
Van Hoving D, Meintjes G, Maartens G, Kengne A
Wellcome Open Res. 2022; 5:72.
PMID: 36325129
PMC: 9608260.
DOI: 10.12688/wellcomeopenres.15824.2.
Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
Wake R, Govender N, Omar S, Ismail F, Tiemessen C, Harrison T
AIDS. 2022; 36(6):839-844.
PMID: 35075041
PMC: 11382303.
DOI: 10.1097/QAD.0000000000003177.
Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals.
Chernick L, Kalla I, Venter M
South Afr J HIV Med. 2021; 22(1):1234.
PMID: 34394971
PMC: 8335785.
DOI: 10.4102/sajhivmed.v22i1.1234.
Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus.
Bjerrum S, Broger T, Szekely R, Mitarai S, Opintan J, Kenu E
Open Forum Infect Dis. 2020; 7(1):ofz530.
PMID: 31976353
PMC: 6966242.
DOI: 10.1093/ofid/ofz530.
Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.
Huerga H, Cossa L, Manhica I, Bastard M, Telnov A, Molfino L
Am J Trop Med Hyg. 2020; 102(3):562-566.
PMID: 31971152
PMC: 7056443.
DOI: 10.4269/ajtmh.19-0493.
Tuberculosis in Hospitalized Patients With Human Immunodeficiency Virus: Clinical Characteristics, Mortality, and Implications From the Rapid Urine-based Screening for Tuberculosis to Reduce AIDS Related Mortality in Hospitalized Patients in Africa.
Gupta-Wright A, Fielding K, Wilson D, van Oosterhout J, Grint D, Mwandumba H
Clin Infect Dis. 2019; 71(10):2618-2626.
PMID: 31781758
PMC: 7744971.
DOI: 10.1093/cid/ciz1133.
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.
Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana R, Zwerling A
Cochrane Database Syst Rev. 2019; 10:CD011420.
PMID: 31633805
PMC: 6802713.
DOI: 10.1002/14651858.CD011420.pub3.
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
Huerga H, Rucker S, Cossa L, Bastard M, Amoros I, Manhica I
PLoS Med. 2019; 16(4):e1002792.
PMID: 31039161
PMC: 6490904.
DOI: 10.1371/journal.pmed.1002792.
Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study.
Songkhla M, Tantipong H, Tongsai S, Angkasekwinai N
Open Forum Infect Dis. 2019; 6(4):ofz132.
PMID: 31024973
PMC: 6475588.
DOI: 10.1093/ofid/ofz132.
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
Thit S, Aung N, Htet Z, Boyd M, Saw H, Anstey N
BMC Med. 2017; 15(1):145.
PMID: 28774293
PMC: 5543584.
DOI: 10.1186/s12916-017-0888-3.
